nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C19—Prednisone—psoriatic arthritis	0.0974	0.187	CbGbCtD
Sitaxentan—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0777	0.149	CbGbCtD
Sitaxentan—CYP2C19—Dexamethasone—psoriatic arthritis	0.0608	0.116	CbGbCtD
Sitaxentan—CYP3A4—Triamcinolone—psoriatic arthritis	0.0589	0.113	CbGbCtD
Sitaxentan—CYP2C9—Dexamethasone—psoriatic arthritis	0.0505	0.0968	CbGbCtD
Sitaxentan—CYP3A4—Betamethasone—psoriatic arthritis	0.0505	0.0968	CbGbCtD
Sitaxentan—CYP3A4—Prednisolone—psoriatic arthritis	0.0498	0.0955	CbGbCtD
Sitaxentan—CYP3A4—Prednisone—psoriatic arthritis	0.0471	0.0902	CbGbCtD
Sitaxentan—CYP3A4—Dexamethasone—psoriatic arthritis	0.0294	0.0563	CbGbCtD
Sitaxentan—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000484	0.00101	CcSEcCtD
Sitaxentan—Bradycardia—Dexamethasone—psoriatic arthritis	0.000482	0.00101	CcSEcCtD
Sitaxentan—Bradycardia—Betamethasone—psoriatic arthritis	0.000482	0.00101	CcSEcCtD
Sitaxentan—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000476	0.000997	CcSEcCtD
Sitaxentan—Haemoglobin—Betamethasone—psoriatic arthritis	0.000476	0.000997	CcSEcCtD
Sitaxentan—Haemorrhage—Betamethasone—psoriatic arthritis	0.000474	0.000991	CcSEcCtD
Sitaxentan—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000474	0.000991	CcSEcCtD
Sitaxentan—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000473	0.000989	CcSEcCtD
Sitaxentan—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000471	0.000985	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00047	0.000983	CcSEcCtD
Sitaxentan—Ataxia—Methotrexate—psoriatic arthritis	0.000469	0.000981	CcSEcCtD
Sitaxentan—Weight decreased—Prednisone—psoriatic arthritis	0.000466	0.000976	CcSEcCtD
Sitaxentan—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000465	0.000973	CcSEcCtD
Sitaxentan—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00046	0.000963	CcSEcCtD
Sitaxentan—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000459	0.00096	CcSEcCtD
Sitaxentan—Visual impairment—Betamethasone—psoriatic arthritis	0.000457	0.000955	CcSEcCtD
Sitaxentan—Visual impairment—Dexamethasone—psoriatic arthritis	0.000457	0.000955	CcSEcCtD
Sitaxentan—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000457	0.000955	CcSEcCtD
Sitaxentan—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000454	0.000949	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.000453	0.000948	CcSEcCtD
Sitaxentan—Myocardial infarction—Prednisone—psoriatic arthritis	0.000451	0.000943	CcSEcCtD
Sitaxentan—Breast disorder—Methotrexate—psoriatic arthritis	0.000451	0.000943	CcSEcCtD
Sitaxentan—Malaise—Prednisolone—psoriatic arthritis	0.000446	0.000933	CcSEcCtD
Sitaxentan—Vertigo—Prednisolone—psoriatic arthritis	0.000444	0.000929	CcSEcCtD
Sitaxentan—Eye disorder—Dexamethasone—psoriatic arthritis	0.000443	0.000927	CcSEcCtD
Sitaxentan—Eye disorder—Betamethasone—psoriatic arthritis	0.000443	0.000927	CcSEcCtD
Sitaxentan—Asthma—Methotrexate—psoriatic arthritis	0.000431	0.000902	CcSEcCtD
Sitaxentan—Angiopathy—Betamethasone—psoriatic arthritis	0.00043	0.0009	CcSEcCtD
Sitaxentan—Angiopathy—Dexamethasone—psoriatic arthritis	0.00043	0.0009	CcSEcCtD
Sitaxentan—Eosinophilia—Methotrexate—psoriatic arthritis	0.000427	0.000893	CcSEcCtD
Sitaxentan—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000422	0.000883	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000421	0.000881	CcSEcCtD
Sitaxentan—Bradycardia—Prednisone—psoriatic arthritis	0.00042	0.000879	CcSEcCtD
Sitaxentan—Alopecia—Dexamethasone—psoriatic arthritis	0.000419	0.000876	CcSEcCtD
Sitaxentan—Alopecia—Betamethasone—psoriatic arthritis	0.000419	0.000876	CcSEcCtD
Sitaxentan—Discomfort—Prednisolone—psoriatic arthritis	0.000416	0.00087	CcSEcCtD
Sitaxentan—Haemoglobin—Prednisone—psoriatic arthritis	0.000415	0.000868	CcSEcCtD
Sitaxentan—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000413	0.000864	CcSEcCtD
Sitaxentan—Haemorrhage—Prednisone—psoriatic arthritis	0.000413	0.000863	CcSEcCtD
Sitaxentan—Malaise—Triamcinolone—psoriatic arthritis	0.00041	0.000858	CcSEcCtD
Sitaxentan—Pancytopenia—Methotrexate—psoriatic arthritis	0.000409	0.000856	CcSEcCtD
Sitaxentan—Malaise—Methylprednisolone—psoriatic arthritis	0.000409	0.000856	CcSEcCtD
Sitaxentan—Vertigo—Triamcinolone—psoriatic arthritis	0.000408	0.000855	CcSEcCtD
Sitaxentan—Vertigo—Methylprednisolone—psoriatic arthritis	0.000408	0.000853	CcSEcCtD
Sitaxentan—Oedema—Prednisolone—psoriatic arthritis	0.000403	0.000844	CcSEcCtD
Sitaxentan—Dysuria—Methotrexate—psoriatic arthritis	0.000403	0.000843	CcSEcCtD
Sitaxentan—Tachycardia—Prednisolone—psoriatic arthritis	0.000394	0.000824	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000393	0.000823	CcSEcCtD
Sitaxentan—Eye disorder—Prednisone—psoriatic arthritis	0.000386	0.000807	CcSEcCtD
Sitaxentan—Infestation NOS—Methotrexate—psoriatic arthritis	0.000384	0.000804	CcSEcCtD
Sitaxentan—Infestation—Methotrexate—psoriatic arthritis	0.000384	0.000804	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000384	0.000802	CcSEcCtD
Sitaxentan—Flushing—Prednisone—psoriatic arthritis	0.000383	0.000801	CcSEcCtD
Sitaxentan—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000383	0.000801	CcSEcCtD
Sitaxentan—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000383	0.000801	CcSEcCtD
Sitaxentan—Discomfort—Triamcinolone—psoriatic arthritis	0.000382	0.0008	CcSEcCtD
Sitaxentan—Discomfort—Methylprednisolone—psoriatic arthritis	0.000382	0.000798	CcSEcCtD
Sitaxentan—Dry mouth—Triamcinolone—psoriatic arthritis	0.000379	0.000792	CcSEcCtD
Sitaxentan—Renal failure—Methotrexate—psoriatic arthritis	0.000378	0.00079	CcSEcCtD
Sitaxentan—Stomatitis—Methotrexate—psoriatic arthritis	0.000374	0.000784	CcSEcCtD
Sitaxentan—Angiopathy—Prednisone—psoriatic arthritis	0.000374	0.000783	CcSEcCtD
Sitaxentan—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000373	0.000781	CcSEcCtD
Sitaxentan—Confusional state—Methylprednisolone—psoriatic arthritis	0.000373	0.000781	CcSEcCtD
Sitaxentan—Immune system disorder—Prednisone—psoriatic arthritis	0.000373	0.00078	CcSEcCtD
Sitaxentan—Malaise—Dexamethasone—psoriatic arthritis	0.000372	0.000778	CcSEcCtD
Sitaxentan—Malaise—Betamethasone—psoriatic arthritis	0.000372	0.000778	CcSEcCtD
Sitaxentan—Oedema—Triamcinolone—psoriatic arthritis	0.000371	0.000776	CcSEcCtD
Sitaxentan—Vertigo—Betamethasone—psoriatic arthritis	0.000371	0.000775	CcSEcCtD
Sitaxentan—Vertigo—Dexamethasone—psoriatic arthritis	0.000371	0.000775	CcSEcCtD
Sitaxentan—Infection—Triamcinolone—psoriatic arthritis	0.000369	0.000771	CcSEcCtD
Sitaxentan—Infection—Methylprednisolone—psoriatic arthritis	0.000368	0.00077	CcSEcCtD
Sitaxentan—Haematuria—Methotrexate—psoriatic arthritis	0.000366	0.000766	CcSEcCtD
Sitaxentan—Insomnia—Prednisolone—psoriatic arthritis	0.000365	0.000764	CcSEcCtD
Sitaxentan—Alopecia—Prednisone—psoriatic arthritis	0.000365	0.000763	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000363	0.00076	CcSEcCtD
Sitaxentan—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000363	0.00076	CcSEcCtD
Sitaxentan—Epistaxis—Methotrexate—psoriatic arthritis	0.000362	0.000758	CcSEcCtD
Sitaxentan—Tachycardia—Triamcinolone—psoriatic arthritis	0.000362	0.000758	CcSEcCtD
Sitaxentan—Mental disorder—Prednisone—psoriatic arthritis	0.000362	0.000756	CcSEcCtD
Sitaxentan—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000361	0.000756	CcSEcCtD
Sitaxentan—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00036	0.000752	CcSEcCtD
Sitaxentan—Malnutrition—Prednisone—psoriatic arthritis	0.000359	0.000752	CcSEcCtD
Sitaxentan—Discomfort—Dexamethasone—psoriatic arthritis	0.000347	0.000726	CcSEcCtD
Sitaxentan—Discomfort—Betamethasone—psoriatic arthritis	0.000347	0.000726	CcSEcCtD
Sitaxentan—Haemoglobin—Methotrexate—psoriatic arthritis	0.000347	0.000725	CcSEcCtD
Sitaxentan—Hypotension—Methylprednisolone—psoriatic arthritis	0.000346	0.000724	CcSEcCtD
Sitaxentan—Pain—Prednisolone—psoriatic arthritis	0.000345	0.000722	CcSEcCtD
Sitaxentan—Hepatitis—Methotrexate—psoriatic arthritis	0.000345	0.000722	CcSEcCtD
Sitaxentan—Haemorrhage—Methotrexate—psoriatic arthritis	0.000345	0.000722	CcSEcCtD
Sitaxentan—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000341	0.000713	CcSEcCtD
Sitaxentan—Urethral disorder—Methotrexate—psoriatic arthritis	0.000338	0.000707	CcSEcCtD
Sitaxentan—Oedema—Betamethasone—psoriatic arthritis	0.000337	0.000704	CcSEcCtD
Sitaxentan—Oedema—Dexamethasone—psoriatic arthritis	0.000337	0.000704	CcSEcCtD
Sitaxentan—Insomnia—Triamcinolone—psoriatic arthritis	0.000336	0.000702	CcSEcCtD
Sitaxentan—Insomnia—Methylprednisolone—psoriatic arthritis	0.000335	0.000701	CcSEcCtD
Sitaxentan—Infection—Dexamethasone—psoriatic arthritis	0.000334	0.0007	CcSEcCtD
Sitaxentan—Infection—Betamethasone—psoriatic arthritis	0.000334	0.0007	CcSEcCtD
Sitaxentan—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000333	0.000697	CcSEcCtD
Sitaxentan—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000332	0.000696	CcSEcCtD
Sitaxentan—Visual impairment—Methotrexate—psoriatic arthritis	0.000332	0.000695	CcSEcCtD
Sitaxentan—Anaemia—Prednisone—psoriatic arthritis	0.000332	0.000695	CcSEcCtD
Sitaxentan—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00033	0.000691	CcSEcCtD
Sitaxentan—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00033	0.000691	CcSEcCtD
Sitaxentan—Agitation—Prednisone—psoriatic arthritis	0.00033	0.000691	CcSEcCtD
Sitaxentan—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00033	0.00069	CcSEcCtD
Sitaxentan—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00033	0.00069	CcSEcCtD
Sitaxentan—Tachycardia—Dexamethasone—psoriatic arthritis	0.000329	0.000687	CcSEcCtD
Sitaxentan—Tachycardia—Betamethasone—psoriatic arthritis	0.000329	0.000687	CcSEcCtD
Sitaxentan—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000327	0.000683	CcSEcCtD
Sitaxentan—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000326	0.000682	CcSEcCtD
Sitaxentan—Malaise—Prednisone—psoriatic arthritis	0.000324	0.000678	CcSEcCtD
Sitaxentan—Vertigo—Prednisone—psoriatic arthritis	0.000323	0.000675	CcSEcCtD
Sitaxentan—Eye disorder—Methotrexate—psoriatic arthritis	0.000322	0.000674	CcSEcCtD
Sitaxentan—Tinnitus—Methotrexate—psoriatic arthritis	0.000322	0.000673	CcSEcCtD
Sitaxentan—Anorexia—Betamethasone—psoriatic arthritis	0.000321	0.000671	CcSEcCtD
Sitaxentan—Anorexia—Dexamethasone—psoriatic arthritis	0.000321	0.000671	CcSEcCtD
Sitaxentan—Urticaria—Prednisolone—psoriatic arthritis	0.000321	0.000671	CcSEcCtD
Sitaxentan—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00032	0.00067	CcSEcCtD
Sitaxentan—Fatigue—Triamcinolone—psoriatic arthritis	0.00032	0.000669	CcSEcCtD
Sitaxentan—Fatigue—Methylprednisolone—psoriatic arthritis	0.000319	0.000668	CcSEcCtD
Sitaxentan—Pain—Triamcinolone—psoriatic arthritis	0.000317	0.000664	CcSEcCtD
Sitaxentan—Hypotension—Dexamethasone—psoriatic arthritis	0.000315	0.000658	CcSEcCtD
Sitaxentan—Hypotension—Betamethasone—psoriatic arthritis	0.000315	0.000658	CcSEcCtD
Sitaxentan—Angiopathy—Methotrexate—psoriatic arthritis	0.000313	0.000655	CcSEcCtD
Sitaxentan—Immune system disorder—Methotrexate—psoriatic arthritis	0.000312	0.000652	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000311	0.00065	CcSEcCtD
Sitaxentan—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000306	0.00064	CcSEcCtD
Sitaxentan—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000305	0.000638	CcSEcCtD
Sitaxentan—Alopecia—Methotrexate—psoriatic arthritis	0.000305	0.000638	CcSEcCtD
Sitaxentan—Insomnia—Dexamethasone—psoriatic arthritis	0.000305	0.000637	CcSEcCtD
Sitaxentan—Insomnia—Betamethasone—psoriatic arthritis	0.000305	0.000637	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000304	0.000636	CcSEcCtD
Sitaxentan—Discomfort—Prednisone—psoriatic arthritis	0.000302	0.000632	CcSEcCtD
Sitaxentan—Mental disorder—Methotrexate—psoriatic arthritis	0.000302	0.000632	CcSEcCtD
Sitaxentan—Malnutrition—Methotrexate—psoriatic arthritis	0.0003	0.000628	CcSEcCtD
Sitaxentan—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000297	0.000622	CcSEcCtD
Sitaxentan—Dyspepsia—Betamethasone—psoriatic arthritis	0.000296	0.00062	CcSEcCtD
Sitaxentan—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000296	0.00062	CcSEcCtD
Sitaxentan—Urticaria—Triamcinolone—psoriatic arthritis	0.000295	0.000617	CcSEcCtD
Sitaxentan—Urticaria—Methylprednisolone—psoriatic arthritis	0.000294	0.000615	CcSEcCtD
Sitaxentan—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000293	0.000614	CcSEcCtD
Sitaxentan—Oedema—Prednisone—psoriatic arthritis	0.000293	0.000613	CcSEcCtD
Sitaxentan—Decreased appetite—Betamethasone—psoriatic arthritis	0.000293	0.000612	CcSEcCtD
Sitaxentan—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000293	0.000612	CcSEcCtD
Sitaxentan—Infection—Prednisone—psoriatic arthritis	0.000291	0.000609	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000291	0.000608	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000291	0.000608	CcSEcCtD
Sitaxentan—Fatigue—Betamethasone—psoriatic arthritis	0.00029	0.000607	CcSEcCtD
Sitaxentan—Fatigue—Dexamethasone—psoriatic arthritis	0.00029	0.000607	CcSEcCtD
Sitaxentan—Pain—Betamethasone—psoriatic arthritis	0.000288	0.000602	CcSEcCtD
Sitaxentan—Pain—Dexamethasone—psoriatic arthritis	0.000288	0.000602	CcSEcCtD
Sitaxentan—Nervous system disorder—Prednisone—psoriatic arthritis	0.000288	0.000602	CcSEcCtD
Sitaxentan—Tachycardia—Prednisone—psoriatic arthritis	0.000286	0.000599	CcSEcCtD
Sitaxentan—Skin disorder—Prednisone—psoriatic arthritis	0.000285	0.000596	CcSEcCtD
Sitaxentan—Anorexia—Prednisone—psoriatic arthritis	0.000279	0.000585	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000279	0.000583	CcSEcCtD
Sitaxentan—Anaemia—Methotrexate—psoriatic arthritis	0.000277	0.000581	CcSEcCtD
Sitaxentan—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000277	0.00058	CcSEcCtD
Sitaxentan—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000277	0.00058	CcSEcCtD
Sitaxentan—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000273	0.000572	CcSEcCtD
Sitaxentan—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000273	0.000571	CcSEcCtD
Sitaxentan—Malaise—Methotrexate—psoriatic arthritis	0.000271	0.000566	CcSEcCtD
Sitaxentan—Vertigo—Methotrexate—psoriatic arthritis	0.00027	0.000564	CcSEcCtD
Sitaxentan—Leukopenia—Methotrexate—psoriatic arthritis	0.000269	0.000562	CcSEcCtD
Sitaxentan—Urticaria—Betamethasone—psoriatic arthritis	0.000267	0.00056	CcSEcCtD
Sitaxentan—Urticaria—Dexamethasone—psoriatic arthritis	0.000267	0.00056	CcSEcCtD
Sitaxentan—Dizziness—Prednisolone—psoriatic arthritis	0.000267	0.000558	CcSEcCtD
Sitaxentan—Asthenia—Triamcinolone—psoriatic arthritis	0.000266	0.000557	CcSEcCtD
Sitaxentan—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000266	0.000557	CcSEcCtD
Sitaxentan—Body temperature increased—Betamethasone—psoriatic arthritis	0.000266	0.000557	CcSEcCtD
Sitaxentan—Asthenia—Methylprednisolone—psoriatic arthritis	0.000266	0.000556	CcSEcCtD
Sitaxentan—Insomnia—Prednisone—psoriatic arthritis	0.000265	0.000555	CcSEcCtD
Sitaxentan—Dyspepsia—Prednisone—psoriatic arthritis	0.000258	0.00054	CcSEcCtD
Sitaxentan—Chest pain—Methotrexate—psoriatic arthritis	0.000256	0.000535	CcSEcCtD
Sitaxentan—Decreased appetite—Prednisone—psoriatic arthritis	0.000255	0.000533	CcSEcCtD
Sitaxentan—Rash—Prednisolone—psoriatic arthritis	0.000254	0.000532	CcSEcCtD
Sitaxentan—Dermatitis—Prednisolone—psoriatic arthritis	0.000254	0.000532	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000254	0.000531	CcSEcCtD
Sitaxentan—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000253	0.00053	CcSEcCtD
Sitaxentan—Fatigue—Prednisone—psoriatic arthritis	0.000253	0.000529	CcSEcCtD
Sitaxentan—Headache—Prednisolone—psoriatic arthritis	0.000253	0.000529	CcSEcCtD
Sitaxentan—Discomfort—Methotrexate—psoriatic arthritis	0.000253	0.000528	CcSEcCtD
Sitaxentan—Constipation—Prednisone—psoriatic arthritis	0.000251	0.000525	CcSEcCtD
Sitaxentan—Confusional state—Methotrexate—psoriatic arthritis	0.000247	0.000517	CcSEcCtD
Sitaxentan—Dizziness—Triamcinolone—psoriatic arthritis	0.000245	0.000513	CcSEcCtD
Sitaxentan—Dizziness—Methylprednisolone—psoriatic arthritis	0.000245	0.000512	CcSEcCtD
Sitaxentan—Infection—Methotrexate—psoriatic arthritis	0.000243	0.000509	CcSEcCtD
Sitaxentan—Feeling abnormal—Prednisone—psoriatic arthritis	0.000242	0.000506	CcSEcCtD
Sitaxentan—Asthenia—Betamethasone—psoriatic arthritis	0.000242	0.000505	CcSEcCtD
Sitaxentan—Asthenia—Dexamethasone—psoriatic arthritis	0.000242	0.000505	CcSEcCtD
Sitaxentan—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00024	0.000503	CcSEcCtD
Sitaxentan—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00024	0.000502	CcSEcCtD
Sitaxentan—Nausea—Prednisolone—psoriatic arthritis	0.00024	0.000501	CcSEcCtD
Sitaxentan—Skin disorder—Methotrexate—psoriatic arthritis	0.000238	0.000498	CcSEcCtD
Sitaxentan—Vomiting—Triamcinolone—psoriatic arthritis	0.000236	0.000494	CcSEcCtD
Sitaxentan—Vomiting—Methylprednisolone—psoriatic arthritis	0.000235	0.000493	CcSEcCtD
Sitaxentan—Rash—Triamcinolone—psoriatic arthritis	0.000234	0.000489	CcSEcCtD
Sitaxentan—Dermatitis—Triamcinolone—psoriatic arthritis	0.000234	0.000489	CcSEcCtD
Sitaxentan—Anorexia—Methotrexate—psoriatic arthritis	0.000234	0.000489	CcSEcCtD
Sitaxentan—Rash—Methylprednisolone—psoriatic arthritis	0.000233	0.000488	CcSEcCtD
Sitaxentan—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000233	0.000488	CcSEcCtD
Sitaxentan—Urticaria—Prednisone—psoriatic arthritis	0.000233	0.000487	CcSEcCtD
Sitaxentan—Headache—Triamcinolone—psoriatic arthritis	0.000232	0.000486	CcSEcCtD
Sitaxentan—Headache—Methylprednisolone—psoriatic arthritis	0.000232	0.000485	CcSEcCtD
Sitaxentan—Body temperature increased—Prednisone—psoriatic arthritis	0.000232	0.000485	CcSEcCtD
Sitaxentan—Diarrhoea—Betamethasone—psoriatic arthritis	0.00023	0.000482	CcSEcCtD
Sitaxentan—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00023	0.000482	CcSEcCtD
Sitaxentan—Hypotension—Methotrexate—psoriatic arthritis	0.000229	0.000479	CcSEcCtD
Sitaxentan—Dizziness—Betamethasone—psoriatic arthritis	0.000223	0.000466	CcSEcCtD
Sitaxentan—Dizziness—Dexamethasone—psoriatic arthritis	0.000223	0.000466	CcSEcCtD
Sitaxentan—Insomnia—Methotrexate—psoriatic arthritis	0.000222	0.000464	CcSEcCtD
Sitaxentan—Nausea—Triamcinolone—psoriatic arthritis	0.00022	0.000461	CcSEcCtD
Sitaxentan—Nausea—Methylprednisolone—psoriatic arthritis	0.00022	0.00046	CcSEcCtD
Sitaxentan—Somnolence—Methotrexate—psoriatic arthritis	0.000218	0.000456	CcSEcCtD
Sitaxentan—Hypersensitivity—Prednisone—psoriatic arthritis	0.000216	0.000452	CcSEcCtD
Sitaxentan—Dyspepsia—Methotrexate—psoriatic arthritis	0.000216	0.000451	CcSEcCtD
Sitaxentan—Vomiting—Betamethasone—psoriatic arthritis	0.000214	0.000448	CcSEcCtD
Sitaxentan—Vomiting—Dexamethasone—psoriatic arthritis	0.000214	0.000448	CcSEcCtD
Sitaxentan—Decreased appetite—Methotrexate—psoriatic arthritis	0.000213	0.000446	CcSEcCtD
Sitaxentan—Rash—Betamethasone—psoriatic arthritis	0.000212	0.000444	CcSEcCtD
Sitaxentan—Rash—Dexamethasone—psoriatic arthritis	0.000212	0.000444	CcSEcCtD
Sitaxentan—Dermatitis—Dexamethasone—psoriatic arthritis	0.000212	0.000444	CcSEcCtD
Sitaxentan—Dermatitis—Betamethasone—psoriatic arthritis	0.000212	0.000444	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000212	0.000443	CcSEcCtD
Sitaxentan—Fatigue—Methotrexate—psoriatic arthritis	0.000211	0.000442	CcSEcCtD
Sitaxentan—Headache—Dexamethasone—psoriatic arthritis	0.000211	0.000441	CcSEcCtD
Sitaxentan—Headache—Betamethasone—psoriatic arthritis	0.000211	0.000441	CcSEcCtD
Sitaxentan—Asthenia—Prednisone—psoriatic arthritis	0.00021	0.00044	CcSEcCtD
Sitaxentan—Pain—Methotrexate—psoriatic arthritis	0.00021	0.000438	CcSEcCtD
Sitaxentan—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000202	0.000422	CcSEcCtD
Sitaxentan—Diarrhoea—Prednisone—psoriatic arthritis	0.000201	0.00042	CcSEcCtD
Sitaxentan—Nausea—Betamethasone—psoriatic arthritis	0.0002	0.000418	CcSEcCtD
Sitaxentan—Nausea—Dexamethasone—psoriatic arthritis	0.0002	0.000418	CcSEcCtD
Sitaxentan—Urticaria—Methotrexate—psoriatic arthritis	0.000195	0.000407	CcSEcCtD
Sitaxentan—Dizziness—Prednisone—psoriatic arthritis	0.000194	0.000406	CcSEcCtD
Sitaxentan—Body temperature increased—Methotrexate—psoriatic arthritis	0.000194	0.000405	CcSEcCtD
Sitaxentan—Vomiting—Prednisone—psoriatic arthritis	0.000186	0.00039	CcSEcCtD
Sitaxentan—Rash—Prednisone—psoriatic arthritis	0.000185	0.000387	CcSEcCtD
Sitaxentan—Dermatitis—Prednisone—psoriatic arthritis	0.000185	0.000386	CcSEcCtD
Sitaxentan—Headache—Prednisone—psoriatic arthritis	0.000184	0.000384	CcSEcCtD
Sitaxentan—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000181	0.000378	CcSEcCtD
Sitaxentan—Asthenia—Methotrexate—psoriatic arthritis	0.000176	0.000368	CcSEcCtD
Sitaxentan—Nausea—Prednisone—psoriatic arthritis	0.000174	0.000364	CcSEcCtD
Sitaxentan—Diarrhoea—Methotrexate—psoriatic arthritis	0.000168	0.000351	CcSEcCtD
Sitaxentan—Dizziness—Methotrexate—psoriatic arthritis	0.000162	0.000339	CcSEcCtD
Sitaxentan—Vomiting—Methotrexate—psoriatic arthritis	0.000156	0.000326	CcSEcCtD
Sitaxentan—Rash—Methotrexate—psoriatic arthritis	0.000154	0.000323	CcSEcCtD
Sitaxentan—Dermatitis—Methotrexate—psoriatic arthritis	0.000154	0.000323	CcSEcCtD
Sitaxentan—Headache—Methotrexate—psoriatic arthritis	0.000154	0.000321	CcSEcCtD
Sitaxentan—Nausea—Methotrexate—psoriatic arthritis	0.000146	0.000305	CcSEcCtD
